Cargando…
Lactobacilli Expressing Broadly Neutralizing Nanobodies against HIV-1 as Potential Vectors for HIV-1 Prophylaxis?
In the absence of an active prophylactic vaccine against HIV-1, passively administered, broadly neutralizing antibodies (bnAbs) identified in some chronically infected persons were shown to prevent HIV-1 infection in animal models. However, passive administration of bnAbs may not be suited to preven...
Autores principales: | Kalusche, Sarah, Vanshylla, Kanika, Kleipass, Franziska, Gruell, Henning, Müller, Barbara, Zeng, Zhu, Koch, Kathrin, Stein, Stefan, Marcotte, Harold, Klein, Florian, Dietrich, Ursula |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768517/ https://www.ncbi.nlm.nih.gov/pubmed/33322227 http://dx.doi.org/10.3390/vaccines8040758 |
Ejemplares similares
-
Predicting in vivo escape dynamics of HIV-1 from a broadly neutralizing antibody
por: Meijers, Matthijs, et al.
Publicado: (2021) -
Design of an optimal combination therapy with broadly neutralizing antibodies to suppress HIV-1
por: LaMont, Colin, et al.
Publicado: (2022) -
CD34T+ Humanized Mouse Model to Study Mucosal HIV-1 Transmission and Prevention
por: Vanshylla, Kanika, et al.
Publicado: (2021) -
Selection of nanobodies with broad neutralizing potential against primary HIV-1 strains using soluble subtype C gp140 envelope trimers
por: Koch, Kathrin, et al.
Publicado: (2017) -
Lactobacilli as a Vector for Delivery of Nanobodies against Norovirus Infection
por: Yuki, Yoshikazu, et al.
Publicado: (2022)